Revolutionizing Government Discount Programs: Why Traditional Methods Fail

Hero_4

The 340B program, exceeding $60 billion and experiencing exponential growth, faces unprecedented challenges exacerbated by the Inflation Reduction Act and Maximum Fair Price regulations. The scale of systemic waste, misaligned incentives, and an industry plagued by middle-men further complicates compliance and transparency efforts.

This webinar addresses the urgent need for advanced technology solutions to ensure compliance, manage drug discounts efficiently, and restore trust among stakeholders in the complex pharmaceutical landscape.

Join the webinar to discuss:
  • Impact of Exponential Growth: Discuss the challenges posed by the rapid expansion of the 340B program and its implications for stakeholders across the pharmaceutical ecosystem.
  • Navigating Regulatory Complexity: Examine the additional layers introduced by the Inflation Reduction Act and Maximum Fair Price regulations, highlighting the need for clear standards and advanced technology solutions to mitigate duplication and ensure compliance.
  • Restoring Trust and Transparency: Analyze how enhanced data access and transparency can foster trust among covered entities, policy makers, and manufacturers
This session leverages insights from covered entities, policy makers, and industry leaders to propose new compliance models and technology solutions essential for the sustainable future of drug discount programs.


With:

Daryl Todd, Kalderos Chief Strategy Officer

Download Now


By submitting this form, I agree that Kalderos may contact me at the email address or phone number above to tell me about its services. See our Privacy Policy for more details or to opt-out at any time.

Covered in this webinar:

  • Impact of Exponential Growth: Discuss the challenges posed by the rapid expansion of the 340B program and its implications for stakeholders across the pharmaceutical ecosystem.
  • Navigating Regulatory Complexity: Examine the additional layers introduced by the Inflation Reduction Act and Maximum Fair Price regulations, highlighting the need for clear standards and advanced technology solutions to mitigate duplication and ensure compliance.
  • Restoring Trust and Transparency: Analyze how enhanced data access and transparency can foster trust among covered entities, policy makers, and manufacturers